| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in EVGN over the last quarter tilts toward buying: insiders added a net 460,000 shares worth roughly $292K. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
The largest recent buyer is RECANATI LEON (Director), now holding an estimated $853K in EVGN.
EVGN sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.34M | $833.2K | +460.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Recanati Leon | Director | Buy | 460,000 | $0.64 | $292,100.00 | +52.0% |